API Contract Manufacturing Market Analysis – Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 125

Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies. The market for API contract manufacturing is expected to witness increased demand in coming years owing to the availability of skilled labor at economic cost, suitable government policies, and tax advantages.

The objective of this study is to outline the market trends and market revenue forecasts for the global API contract manufacturing market for the future years. The report emphasizes on outlining and describing the major factors influencing the growth of global API contract manufacturing market. It provides an analysis of market size, different geographic regions, market segments, market share, key players, and premium industry trends. The report identifies the major market events including product launches, mergers & acquisitions, technological developments, and advanced business strategies chosen by key market players. Along with strategically analyzing key micro markets, the report also concentrates on various drivers, opportunities, restraints, and challenges present in the API contract manufacturing market. The market research report encompasses the API contract manufacturing market by its major segments, which include segmentation by type, synthesis, therapeutic area, drug type, and major geographic regions.

On the basis of geography, North America is the market leader in API contract manufacturing market. The U.S. contributes around one-fifth of the world’s market share. Some of the factors driving the growth of API contract manufacturing market include enhanced technical innovations leading to proliferation in novel APIs production, high demand for novel bio-generic drugs and limited production cost of APIs. The Asia-Pacific market is evolving and is ranked among the most attractive API contract manufacturing markets. Owing to the high costs of APIs production in Western Countries, India and China have become most preferred regions for outsourcing of contract manufacturing. These countries are ranked among the most stable democracies and are gifted with advanced technologies. Also, it has become an experienced market region for outsourcing API contract manufacturing as large number of international companies are outsourcing API manufacturing to this region. Also, this region possesses a large technical manpower and is further developing owing to technological developments, which will further boost the market growth.

As per BoehringerIngelheim GmbH, nations such as India and China, which currently supply over half of APIs utilized in the U.S., will command more than 80% share in the upcoming years. Some of the leading players in global API contract manufacturing market include Ranbaxy Laboratories Ltd., AstraZeneca Plc, Teva Pharmaceuticals Industries Ltd, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd, BoehringerIngelhein GmbH, Novartis AG, Sun Pharmaceutical Industries Ltd., Piramal Pharma Solutions, Sandoz-Lek-Biochemie, GlaxoSmithKline Pharmaceuticals Ltd. and others.

The presence of low cost labor in emerging countries, easy availability of resources, and access to the advanced technologies are the major factors driving the API contract manufacturing market. Factors providing remarkable growth opportunities for the API contract manufacturing market in the future include rising need to concentrate on the core activities and to accelerate the drug development processes. Apart from that, a substantial reduction in time-to-market process will provide major growth opportunities in the market.


Related Reports

Sterility Indicators Market (By Type - Chemical Indicators, Biological Indicators; By Technique - Heat Sterilization, Low Temperature Sterilization, Filtration, Sterilization, Radiation Sterilization, Liquid Sterilization; By End-user - Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical, laboratories/Research Centers, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to dr

Complementary and Alternative Medicine Market (By Intervention - Botanicals [Ayurveda, Naturopathy, Homeopathy], Acupuncture, Mind, Body, and Yoga [Chakra Healing, Hypnotherapy, Yoga, Meditation, Energy Healing], Magnetic Intervention; By Distribution Method - Direct Contact, E-training, Distance Correspondence) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global complementary and alternative medicine market size is expected to around USD 199.2 billion by 2026, the market is projected to grow with 19% CAGR during the forecast time period. The market is driven by government initiatives in numerous nations to augment the reach of these medicines. Market

Sinus Dilation Devices Market (By Product - PBalloon Sinus Dilation Devices, Endoscopes, Sinuscopes, Rhinoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus, Surgery (FESS) Instruments Set, Others; By End-user - Hospitals, ENT Clinics, Ambulatory Surgery Centres; By Procedure - Stand-alone, Hybrid; By Application - Adult, Pediatric) - Global Industry Size, Share, Trends, and Forecast 2018 - 2026

Introduction The global sinus dilation devices market is project to reach USD 4.0 billion by 2026 in terms of volume and the market is projected to showcase 9.1% CAGR during the forecast period. The market is driven by emergence of advanced technology in healthcare sectordrives the need for sinus dilation devices. Ma

mHealth Market (By Services - Connected Sensors [Inhaler Sensors, Injection Sensors], Integrated Connected Devices [ Integrated Inhaler, Integrated Injection];By Technology - Bluetooth, NFC, Other Technologies (Cellular, Low Power Wide Area Network); By Participants - Healthcare Providers, Homecare Centers) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global mhealth market is project worth $152.2 Billion in 2026 and the market is projected to showcase 26.1% CAGR during the forecast period. The market is driven by increasing in need for digitalization especially in healthcare sector and also increase in number of chronic illness throughout the globe. Market Dynamic

Neurovascular Embolectomy Device Market (Type: Aspiration devices, Stent retrievers) - Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Introduction Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift wi

Herbal Supplements Market (By Product - Moringa, Echinacea, Flaxseeds, Turmeric, Ginger, Ginseng; By Consumer - Pregnant women, Adult, Pediatric, Geriatric; By Formulation - Tablets, Capsules, Liquid, Powder and Granules, Soft gels, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global herbal supplements market is project worth $9.0 Billion in 2026 and the market is projected to showcase 6.7% CAGR during the forecast period. The market is driven by growing healthcare spending. Market Dynamics Rising geriatric population and aler

Cart Summary